Matt’s TEDx Talk…Educating The Attendees & The Public On The Impact of Patient Advocacy
🎉 Today is a milestone moment for the entire Archo Advocacy community 🎉
📢 We just released the 2025 ELAVAY Advocacy Intelligence Report!
The 2025 ELAVAY Advocacy Intelligence report is our most comprehensive benchmark yet, spotlighting how 80+ healthcare companies engage with patient advocates across partnerships, policy, access, equity, and impact.
Some of this year’s standouts:
Janssen: Top performer in Disease Education & Patient Access.
Pfizer/Seagen: Leading in Advisory Boards & Scientific Exchange.
Sanofi/Genzyme: Major gains in Financial & Coalition Support.
Gilead/Kite, Genentech/Roche, and Lundbeck: Emerging leaders in research-aligned education, registry support, and insight collaboration.
But this report does more than rank performance, it calls out the gap between advocacy rhetoric and reality. Many teams are underfunded, undervalued, and understaffed. ELAVAY equips you with the intelligence to close that gap and lead with legitimacy.
At Archo, we advocate for Advocacy.
We believe the best way to elevate the function is to equip those within it with the tools they deserve: real benchmarking data through our BIOADVOCATE BENCHMARK on team budgets and structures, census-level insights on how advocacy is resourced, and clear-eyed analysis of how to run an effective advocacy function, and why.
The ELAVAY Report doesn’t just celebrate top performers. It serves as a strategic mirror, helping every company understand how to better align with the expectations of patients, caregivers, and the advocacy community itself. If organizations do not like their ranking, unlike other reports in the space, Archo can instruct and guide these teams on exactly how they can change the public perception of their team.
You can hear more about this year’s ELAVAY Report and insights from the BIOADVOCATE BENCHMARK Report at the upcoming CPO Summit. Archo Advocacy is proud to sponsor the 5th Chief Patient Officer Summit on July 22-23, in Boston, MA. This premier event will unite life science leaders, Chief Patient Officers, advocacy executives, and patient-centric innovators to advance one shared mission: to embed the patient voice into the heart of healthcare strategy. Sessions will explore the impact of advocacy, build cross-functional alignment, and translate SDOH initiatives into enterprise value. Whether you're looking to refine advocacy metrics, expand your stakeholder influence, or build deeper relationships across the enterprise, THIS is the must-attend 2025 event. Register today and save 15% off with discount code SPONSOR327: https://dgevents.com/event/chief-patient-officer-summit/
Because advocacy isn’t a feel-good afterthought. It’s a frontline strategy—and it’s time we treated it like one.
📰 Read the full press release HERE
🎤 PLUS: My TEDx Talk Is Live
I had the honor of taking the stage at TEDxCharleston to share why “Advocacy is not a department—it’s a strategy.” This talk is deeply personal. It’s also a call to action for anyone building healthcare solutions that claim to be “patient-centered.”
▶️ Watch now on YouTube: https://www.youtube.com/watch?v=2Rkzqosn2RQ
Matt with the titanium in his spine in the background…
Let’s redefine what leadership looks like in healthcare—starting with the patients we serve.
With purpose,
Matt Toresco
Founder, CEO & Chief Patient Officer, Archo Advocacy, LLC
https://archo.io | https://elavayreport.com | @ArchoAdvocacy